This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
1/6 16:25
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are the two most valuable healthcare companies in the world. Combined, they're worth nearly $1.4 trillion. And it's conceivable that their individual valuations could top $1 trillion in the future. How they got here is no mystery...